MASH Gets Mashed: Fibrosis Falls, Liver Up, Hopes Rise 💪🧬🚀
May 01, 2025•4 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Semaglutide 2.4 mg weekly led to significant resolution of MASH and reduction in fibrosis after 72 weeks 🌟🧬.
Patients lost more weight ⚖️, showed better liver markers 📉, and had improved metabolic profiles 💉.
GI side effects were common 🤢, but no new safety signals emerged ✅.
Promising dual-action therapy for liver and cardiometabolic health! ❤️🩺
For the best experience, listen in Metacast app for iOS or Android